Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
458
datasets available to search
ShareScore release 0.9.0
Dataset results
458 results for “clinical research”
The clinical impact of high-profile animal-based research reported in the UK national press: a detailed discussion of articles from 1995, and full search results from the Nexis database
Open the record for dataset details and reuse information.
Recruitment and retention strategies for improving representation in clinical research: A meta-synthesis
Open the record for dataset details and reuse information.
Clinician-researcher’s perspectives on clinical research during the COVID-19 pandemic
Open the record for dataset details and reuse information.
Are researchers moving away from animal models as a result of poor clinical translation in the field of stroke? an analysis of opinion papers
Open the record for dataset details and reuse information.
Intensive care unit patients' opinion on enrollment in clinical research: a multicenter survey - Study data bank
<p><span><span><span><span><span><span><span><span><span><span><span><b>Background:</b> In most emergency situations or severe illness, patients are unable to consent for clinical trial enrollment. In such circumstances, the decision about whether to participate in a scientific study or not is made by a legally designated representative.</span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>Objective: </b>To address the willingness of patients admitted to the intensive care unit (ICU) to be enrolled in a scientific study as volunteers, and to assess the agreement between patients' and their legal representatives' opinion concerning enrollment in a scientific study.</span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>Methods:</b><b> </b>This survey was conducted in two hospitals in São Paulo, Brazil. Patients (≥18 years) with preserved cognitive functions accompanied by a surrogate admitted to the ICU were eligible for this study. A survey containing 28 questions for patients and 8 questions for surrogates was applied within the first 48h from ICU admission. The survey for patients comprised three sections: demographic characteristics, opinion about participation in clinical research and knowledge about the importance of research. The survey for legal representatives contained two sections: demographic characteristics and assessment of legal representatives' opinion in authorizing patients to be enrolled in research.</span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>Results:</b><b> </b>Between January 2017 and May 2018, 208 pairs of ICU patients and their respective legal representatives answered the survey. Out of 208 ICU patients answering the survey, 73.6% (153/208) were willing to be enrolled in the study as volunteers. Of those patients, 65.1% (97/149) would continue participating in a research even if their legal representative did not support their enrollment. Agreement between patients' and surrogates' opinion concerning participation was poor [Kappa=0.11 (IC95% -0.02 to 0.25)]. If a consent for study participation had been obtained, 69.1% (103/149) of patients would continue participating in the study until its conclusion, and 23.5% (35/149) would allow researchers to use data collected to date, but would withdraw from the study on that occasion.</span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>Conclusion:</b><b> </b>The majority of patients admitted to the ICU were willing to be enrolled in a scientific study as volunteers, also after a deferred informed consent procedure has been used. Nevertheless, contradictory opinions between patients and their and their legal representatives' concerning enrollment in a scientific study were often observed.</span></span></span></span></span></span></span></span></span></span></span></p>
Data from: Automatic recognition of self-acknowledged limitations in clinical research literature
Objective: To automatically recognize self-acknowledged limitations in clinical research publications to support efforts in improving research transparency. Materials and Methods: To develop our recognition methods, we used a set of 8,431 sentences from 1,197 PubMed Central articles. A subset of these sentences was manually annotated for training/testing and inter-annotator agreement was calculated. We cast the recognition problem as a binary classification task, in which we determine whether a given sentence from a publication discusses self-acknowledged limitations or not. We experimented with three methods: a rule-based approach based on document structure, supervised machine learning, and a semi-supervised method that uses self-training to expand the training set in order to improve classification performance. The machine learning algorithms used were logistic regression (LR) and support vector machines (SVM). Results: Annotators had good agreement in labeling limitation sentences (Krippendorff's α=0.781). Of the three methods used, the rule-based method yielded the best performance with 91.5% accuracy (95% CI [90.1-92.9]), while self-training with SVM led to a small improvement over fully supervised learning (89.9%, 95% CI [88.4-91.4] vs. 89.6%, 95% CI [88.1-91.1]). Discussion: We attribute the effectiveness of the rule-based method to the highly localized and formulaic language used in reporting of limitations in clinical research publications. Experiments with training size and composition show that more data does not necessarily lead to higher accuracy in the machine learning-based approaches. Conclusion: The approach presented can be incorporated into the workflows of stakeholders focusing on research transparency to improve reporting of limitations in clinical studies.
Clinical medical research use case evaluation of the VFramework
<p>Context models, straces, etc. created for application of the VFramework.</p>
Figure 2 from: Klein A, Ghosh S (2016) Graph-based clinical diagnosis and prediction using multi-modal neuroimaging data. Research Ideas and Outcomes 2: e8835. https://doi.org/10.3897/rio.2.e8835
Figure 2 - Examples of automatically extracted features (MRI) (a) Example structural features (left lateral views of volumes, surfaces, curves, and points) (b) Schematic feature hierarchy: 3-D gyrii surround a 2-D sulcal ribbon with 1-D fundus containing 0-D pits
Figure 1 from: Klein A, Ghosh S (2016) Graph-based clinical diagnosis and prediction using multi-modal neuroimaging data. Research Ideas and Outcomes 2: e8835. https://doi.org/10.3897/rio.2.e8835
Figure 1 - Examples of graph-based representations of scientific data among hundreds on the www.visualcomplexity.com website (categories on the site include biology, food webs and semantic, social, and knowledge networks). Lower left images of DTI, connectome, and network hubs are from Olaf Sporns (2010, Scholarpedia, 5(2):5584).
Figure 3 from: Klein A, Ghosh S (2016) Graph-based clinical diagnosis and prediction using multi-modal neuroimaging data. Research Ideas and Outcomes 2: e8835. https://doi.org/10.3897/rio.2.e8835
Figure 3 - Example of a graph-based representation of MRI and DTI features (a) A gray/white matter surface (left lateral view) with (visible) sulcal pits highlighted. These features go by different names (sulcal roots, buried gyrii, annectant gyrii, plis de passage) and may be well conserved structures formed early in development. (b) DTI connectivity graph computed on the same patient with depression as on the left panel. Vertices represent automatically extracted sulcal pits and each edge indicates a connection probability greater than 0.01 between two vertices.
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)
ClinicalTrials.gov study NCT01804140. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Research of S-1 Versus Pemetrexed in the Maintenance Treatment of Advanced NSNSCLC
ClinicalTrials.gov study NCT03700333. IPD Sharing: UNDECIDED. Countries: 0. Publications: 3.
Fluids and Catheters Treatment Trial (FACTT) - ARDS Clinical Research Network
ClinicalTrials.gov study NCT00281268. IPD Sharing: Not stated. Countries: 0. Publications: 4.
Research on the Clinical Effect of Effective Prescription in Treating Unstable Angina.
ClinicalTrials.gov study NCT03171597. IPD Sharing: UNDECIDED. Countries: 0. Publications: 5.
Clinical Research on the Efficacy of Acupuncture Treatment in Chronic Low Back Pain
ClinicalTrials.gov study NCT00815529. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Analyzing Clinical Research Participation of Patients With Spinal Cord Injury
ClinicalTrials.gov study NCT05831163. IPD Sharing: UNDECIDED. Countries: 0. Publications: 3.
Research on the Clinical Effect of Xuefu Zhuyu Decoction in Treating Unstable Angina.
ClinicalTrials.gov study NCT03179618. IPD Sharing: UNDECIDED. Countries: 0. Publications: 5.
Chronic Prostatitis Collaborative Research Network Clinical Trial- Ciprofloxacin and Tamsulosin
ClinicalTrials.gov study NCT04552431. IPD Sharing: YES. Countries: 0. Publications: 1.
SmartMouth Advanced Clinical Formula Clinical Research Design Protocol
ClinicalTrials.gov study NCT02709785. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Research Studying a Method of Intervention for Children Diagnosed With Anxiety Disorder: Attentional Bias Intervention
ClinicalTrials.gov study NCT00482820. IPD Sharing: Not stated. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.